Categories: Tech and Auto

Dassault Systemes cuts annual revenue outlook, sees AI boost from 2026

By Olivier Cherfan (Reuters) -French software maker Dassault Systemes cut its full-year revenue growth outlook on Thursday and posted third-quarter results below estimates, pressured by lower-than-anticipated performance in…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by NewsX Syndication
Published: October 23, 2025 12:47:41 IST

By Olivier Cherfan (Reuters) -French software maker Dassault Systemes cut its full-year revenue growth outlook on Thursday and posted third-quarter results below estimates, pressured by lower-than-anticipated performance in its Life Sciences and CENTRIC PLM divisions. The firm adjusted its annual revenue growth outlook to 4%-6% from 6%-8%, while confirming a 7%-10% increase in diluted earnings per share. The group, which sells its software to automakers, plane makers and industrial companies, reported flat third‑quarter revenue, slightly missing expectations. Quarterly sales reached 1.46 billion euros ($1.7 billion) and operating profit 440 million euros, coming in 3% and 2% below the average forecasts of analysts polled by LSEG. J.P. Morgan said in a note that the results missed expectations, citing softer third-quarter growth and a larger-than-expected cut to outlook. "This is going to require significant unpacking for investors to understand the incremental weakening in Medidata and the nature of the Centric PLM SaaS transition," the broker said. On AI development, Chief Financial Officer Rouven Bergmann told Reuters he doesn't expect a significant impact on revenue in 2025. "But 2026 … I don't want to be too optimistic, but also not pessimistic; everything takes time, but think about a ballpark for probably around 50 million to 100 million next year, where we would definitely start to see things shifting, and then from there very accelerated," Bergmann said. Dassault Systèmes' unit Medidata said it has expanded its partnership with Sanofi to enhance clinical research through its Medidata Patient, Data and Study Experiences platforms, aiming to streamline trials, accelerate the delivery of new therapies, and improve patient outcomes. ($1 = 0.8575 euros) (Reporting by Olivier Cherfan in Gdansk; Editing by Sherry Jacob-Phillips and Mrigank Dhaniwala)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by NewsX Syndication
Published: October 23, 2025 12:47:41 IST

Recent Posts

Why Has Kanye West Postponed His First-Ever India Concert In Delhi? Here’s The Truth As Grammy-Winning Rapper Shares New Dates Amid Sudden Delay, Check Updated Schedule Here

Kanye West rapper’s highly anticipated first-ever concert in the country has been officially postponed, with…

March 16, 2026

IPL 2026: RCB vs SRH Opener at M Chinnaswamy Stadium? Karnataka Government Gives Massive Update

RCB vs SRH IPL 2026 opener at M. Chinnaswamy Stadium has received Karnataka Government approval.…

March 16, 2026

Who Is C.C. Mukundan? CPI-Expelled Nattika MLA In Spotlight Amid Reports He May Contest As A BJP Candidate In The 2026 Kerala Assembly Elections

According to the political observers, the step taken by C.C. Mukundan may have broader consequences…

March 16, 2026